Printer-friendly version

Latest News

Read ASCA’s Expanded Analysis of Medicare’s 2015 Proposed Payment Rule
July 22, 2014
While the proposal accommodates some important requests made by ASCA and the ASC community, the disparity in payments between HOPDs and ASCs continues to grow.

Recall of Sterile Drugs by Downing Labs (aka NuVision Pharmacy)
July 21, 2014
FDA investigators inspected NuVision and observed insanitary conditions that result in a lack of sterility assurance of purportedly sterile drug products produced by the company, which puts patients at risk.

ASCA Lobbies for Colorectal Cancer Prevention Legislation
July 17, 2014
ASCA staff joined the American Cancer Society Cancer Action Network (ACSCAN) on Capitol Hill to promote colorectal cancer prevention legislation.

What Procedures Should Be Added to the Medicare List for ASCs?
July 17, 2014
ASCA is conducting a brief survey to determine which procedures should be added to the list of ASC payable procedures for 2015.

Support Clinical and Operational Excellence in Your ASC
July 16, 2014
Join with top experts in ASC management to delve into some of the most critical clinical and operational issues confronting ASCs today and find ways to strategically position your ASC for future success at ASCA’s 2014 Fall Seminar in Scottsdale, Arizona, this October.

Ribbon-Cutting Ceremony Celebrates Newly Renovated ASCA Office
July 16, 2014
ASCA Past President Nap Gary, ASCA President Terry Bohlke, ASCA CEO Bill Prentice and ASCA staff celebrate the completed renovations of the ASCA office in Alexandria, Virginia, with a ribbon-cutting ceremony.

Recall of All Sterile Drugs from Unique Pharmaceuticals
July 15, 2014
Health care professionals should immediately check their medical supplies, quarantine any sterile drug products from Unique Pharmaceuticals, and not administer them to patients.

Read the August Issue of ASC Focus Magazine
July 15, 2014
Read the latest issue to learn how to boost your business office, how to avoid perioperative complications with a careful patient assessment plan and compliance tips for small ASCs.

Informed Consent in the ASC: Legal Considerations and Implications
July 14, 2014
Examine the informed consent process in the ASC setting and the ways that informed consent applies. Learn what your ASC and its staff need to do to protect your facility from litigation during ASCA's next webinar.

Mold Contamination in Hospira Lactated Ringers and 5% Dextrose Injection Flexible Containers
July 11, 2014
Hospira, Inc. announced it is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container. Anyone with an existing inventory should stop use and distribution, quarantine the product immediately.

News Archive >